A SpiceJet flight carrying the vaccines left for the national capital around 8 am, three hours after three trucks with the maiden consignment of the vaccines rolled out of the Serum Institute of India facility, 15 km from the airport.
Three temperature-controlled trucks rolled out of the Serum Institute gates shortly before 5 am and left for Pune airport, from where the vaccines will be flown across India.
Pune-based vaccine major Serum Institute of India (SII) on Monday said it has received an order from the government for as many as 11 million vaccine doses of Covishield, ahead of the January 16 mega vaccination drive.
Is your skincare routine essentially complete by simply using a cleanser, toner, moisturizer? In order to achieve that smooth and glossy skin one must begin with serums. Serums are the pinnacle of gold captured in a small bottle for the eternal youthful skin.
Drugs Controller General of India grants permission to Serum Institute of India to manufacture its COVID-19 vaccine ‘Covishield’. The Pune-based company earlier stated that ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.
Poonawalla'' remarks came soon after after India's drugs regulator, Drug Controller General of India (DCGI) approved Covishield for restricted emergency use.
Samajwadi Party president Akhilesh Yadav Saturday termed the COVID-19 vaccines to be rolled out in the country as "vaccine of the BJP" and said he would not take the shot, drawing a sharp retort from the ruling party which accused him of "insulting" the doctors and scientists.
The subject expert committee (SEC) of the national drugs regulator will meet again on Friday to take a decision on the emergency-use authorisation (EUA) application of Serum Institute of India’s (SII) Oxford-AstraZeneca and Bharat Biotech’s vaccine candidates against Coronavirus disease (Covid-19).
Serum Institute of India's application for emergency use authorisation will be considered by the expert panel today. This development comes hours after the UK government accepted the recommendation from the Medicines and Healthcare Regulatory Agency (MHRA) to authorise Oxford University-AstraZeneca's Covid-19 vaccine, named Covishield, for emergency use.
The applications of Bharat Biotech, Serum Institute and Pfizer seeking emergency use authorisation for their COVID-19 vaccines are being examined, the Centre said on Tuesday asserting that drug regulator DCGI seeking more data from these companies will not impact the vaccine-roll out timeline.
Australian Ambassador to India Barry O'Farrell lauded the country's effort on development of a vaccine against coronavirus saying, "There're many vaccines being produced in countries around the world but there's only one country that has the manufacturing capacity to produce sufficient quantities to satisfy the demands of citizens in every country & that's India."
Covishield is logistically feasible for distribution in India's both urban and rural parts as it can be stored at two to eight degrees Celsius, which is an ideal temperature for being kept in cold storages in the country.
Pune-based Serum Institute of India (SII) has collaborated with the University of Oxford and the British-Swedish pharmaceutical company AstraZeneca for making the Covid-19 vaccine, ‘‘Covidshield’‘, and is conducting trials in India.
Vaccine major Serum Institute of India on Sunday rejected charges that a COVID-19 vaccine candidate has serious side effects, and threatened to seek heavy damages for "malicious" allegations.
After visiting Zydus Cadila's plant in Ahmedabad and Bharat Biotech in Hyderabad, Prime Minister Narendra Modi who is on a day-tour to review coronavirus vaccines development across different hubs in the country has reached Pune in Maharashtra. He will visit Serum Institute of India (SII) which is manufacturing Oxford-AstraZeneca's Covishield vaccine for the contagious disease.
Top News
